Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan, TD; Nagarajan, R; Godown, J.
Cardiology Clinics.
2019;
37:533-544.
Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations.
Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B.
Pediatric Blood and Cancer.
2020;
67.
Can a children's hospital still cut it? Comparing outcomes of pediatric, adolescent and young adult patients undergoing thoracic surgery for lung metastases.
Scorletti, F; Cooke-Barber, J; Pressey, JG; Nagarajan, R; Turpin, B; Jenkins, T; Dasgupta, R.
Pediatric Blood and Cancer.
2020;
67.
Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.
Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al.
Pediatric Blood and Cancer.
2019;
66.
Quality of life of patients with osteosarcoma in the european american osteosarcoma study-1 (EURAMOS-1): Development and implementation of a questionnaire substudy.
Calaminus, G; Jenney, M; Hjorth, L; Baust, K; Bernstein, M; Bielack, S; De Vos, P; Hogendoorn, PC W; Jovic, G; Krailo, M; et al.
JMIR Research Protocols.
2019;
8:e14406-e14406.
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.
Nagarajan, R; Gerbing, R; Alonzo, T; Johnston, DL; Aplenc, R; Kolb, EA; Meshinchi, S; Barakat, LP; Sung, L.
Cancer Medicine.
2019;
8:4454-4464.
Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.
Ryan, TD; Nagarajan, R; Godown, J.
Current Treatment Options in Oncology.
2019;
20.
Study of Delayed Antibiotic in Pediatric Febrile Immunocompromised Patients and Adverse Events.
Fananapazir, N; Dandoy, C; Byczkowski, T; Lane, A; Nagarajan, R; Hariharan, S.
Hospital Pediatrics.
2019;
9:379-386.
Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist, AS; Chen, Y; Teh, JB; Sun, C; Birch, JM; van den Bos, C; Diller, LR; Dilley, K; Ginsberg, J; Martin, LT; et al.
Cancer.
2019;
125:1373-1383.
Sentinel lymph node biopsy in head and neck rhabdomyosarcoma.
Turpin, B; Pressey, JG; Nagarajan, R; Weiss, BD; Trout, AT; Gelfand, MJ; Pater, L; Vatner, RE; Breneman, JC; Dasgupta, R.
Pediatric Blood and Cancer.
2019;
66:e27532-e27532.